Proceedings of the DIA WOrkshop on Multiregional Clinical Trials, October 26-27, 2010

Title
Proceedings of the DIA WOrkshop on Multiregional Clinical Trials, October 26-27, 2010

Abstract
DIA, FDA, and the pharmaceutical industry jointly organized an international workshop on October 26–27, 2010, in Washington, DC. Aptly called Ensuring Quality and Balancing Risks for Multiregional Clinical Trials: Clinical, Regulatory, and Ethical Factors, the workshop drew eminent speakers and participants from Australia, Canada, China, the European Union, and the United States. At the workshop, global leaders from industry, academia, and national regulatory authorities presented strategies to overcome risks, maximize efficiencies, and create a clear path forward on multiregional clinical trials (MRCTs). The 2010 workshop was designed as a follow-up to the October 29–30, 2007, FDA/PhRMA workshop titled Challenges and Opportunities of Multiregional Clinical Trials held in Bethesda, MD. The 2010 workshop provided a platform for the advancement of best practices for MRCTs.